generic glp 1 fda approved Diabetes patients now have access to first GLP-1 medication: ‘More accessible and affordable’ The @U.S. Food and Drug

As a result, future obesity management is likely to prioritize integrated approaches that combine pharmacotherapy with lifestyle interventions, rather than replacing lifestyle changes with medication alone

Accordingly, the diabetes drug market is expected to balloon from $29.81 billion in 2021 to $61.6 billion by 2030

Access to GLP-1 weight loss drugs in the US, Canada, Switzerland, and Germany

The most common side effects are gastrointestinal: nausea (~45%), diarrhea (~22%), constipation (~15%), and vomiting (~13%)

Quercetin alleviates lipopolysaccharide-induced acute kidney injury in mice by suppressing TLR4/NF-B pathway

Mushroom cells naturally bioencapsulate recombinant proteins within their cellular matrix, protecting them from gastric degradation and enabling mucosal immune stimulation following oral administration